Question explored with the scientific record
Is there a Relief for fibromyalgia?
The short version: exercise and movement therapies have the best evidence for reducing fibromyalgia pain and improving function. Drugs show only modest, inconsistent effects with frequent side effects.
The strongest evidence points to structured exercise, not pills. A 2022 review of treatments for juvenile fibromyalgia found that combined neuromuscular exercise and cognitive-behavioral therapy was the most evidence-based approach to reducing pain and fear of movement [1]. A 2024 meta-analysis of 15 randomized trials showed that traditional Chinese exercise (tai chi, qigong) significantly reduced pain on the VAS scale by about 2 points and improved sleep quality by over 2 points on the PSQI [7]. A 2018 study found that 12 weeks of Zumba dancing cut average pain from 6.2 to 4.5 on a 10-point scale [5]. Even Nordic walking at moderate intensity improved fitness without worsening symptoms in a 2011 trial of 67 women [2].
Drugs perform poorly in comparison. The three FDA-approved drugs—duloxetine, pregabalin, and milnacipran—produce a 50% pain reduction in only 10% to 25% of patients [8]. A 2025 systematic review of juvenile fibromyalgia trials found that duloxetine failed its primary pain endpoint in adolescents and produced serious psychiatric side effects including suicidality, while pregabalin failed its primary pain endpoint entirely [4]. In adults, a 2009 pooled analysis found that duloxetine's effect correlates most strongly with pain reduction, but the absolute benefit over placebo is small [13]. The NNT (number needed to treat for one person to get 50% pain relief) runs around 7 to 10, meaning 7 to 10 people must take the drug for one to benefit that much [37, 39]. Meanwhile, about 20% get nausea from duloxetine, and dropout rates for side effects reach 15% at 60 mg and 27% at 120 mg [39].
The most striking finding comes from a 2024 trial comparing hyperbaric oxygen therapy (HBOT) to drugs for fibromyalgia related to childhood sexual abuse [21]. After 60 sessions of HBOT, 29% of patients no longer met fibromyalgia criteria. Zero patients in the drug group had that outcome. The drug group showed no significant improvement on the primary fibromyalgia impact score. HBOT improved pain, emotional symptoms, and brain perfusion on SPECT imaging. The effect size was large (Cohen's d = -1.27 for the FIQ). Mild ear barotrauma occurred in 29% of the HBOT group, but no serious adverse events were reported.
My call: exercise therapies and HBOT are the most promising options. Drugs offer modest, inconsistent benefit with substantial side effects. Confidence is moderate—the exercise evidence is decently broad, the HBOT finding is from a single moderate-sized trial and needs replication.
| Treatment | Pain reduction | Key limitations |
|---|---|---|
| Structured exercise (aerobic, Zumba, tai chi) | ~1.5–2 points on 10-point scale | Adherence varies; benefit is gradual |
| Cognitive-behavioral therapy + exercise | Improves function and mood more than pain | Best as combination, not alone |
| Hyperbaric oxygen therapy | Large effect (d = -1.27); 29% no longer meet FM criteria | Single trial; requires 60 sessions; ear barotrauma in 29% |
| Duloxetine 60–120 mg/day | ~10–25% get 50% pain relief; NNT 7–10 | Nausea ~20%; dropout 15–27%; suicidality risk in adolescents |
| Pregabalin 300–450 mg/day | NNT ~5–11 for 30–50% pain reduction | Dizziness, weight gain; failed primary endpoint in adolescent trial |
| Milnacipran 100–200 mg/day | Modest benefit; responder rate ~15–25% vs 9–19% placebo | High dropout (34–35%); nausea, headache |
Sources used 10
-
Non-Pharmacological Treatments in Juvenile Fibromyalgia. Systematic Review of Clinical Trials
This 2022 systematic review evaluates non-pharmacological treatments for juvenile fibromyalgia, identifying integrative neuromuscular exercise and cognitive-behavioral therapy—especially in combination—as the most evidence-based approach to reducing pain and improving function i…
DOI: 10.33790/jcrp1100101 -
Nordic walking in fibromyalgia: a means of promoting fitness that is easy for busy clinicians to recommend
The study investigates the effects of moderate-to-high intensity Nordic walking on functional capacity and pain in women with fibromyalgia, finding significant improvements in fitness without exacerbating symptoms.
DOI: 10.1186/ar3225 -
Management of Juvenile Fibromyalgia: A Level I Evidence-Based Systematic Review
This Level I evidence-based systematic review synthesizes randomized controlled trials evaluating pharmacological (duloxetine, milnacipran, pregabalin) and non-pharmacological (CBT, exercise-based, FIT Teens) treatments for juvenile fibromyalgia, finding modest analgesia for dru…
DOI: 10.3390/medsci13030203 -
Zumba dancing can improve the pain and functional capacity in women with fibromyalgia
This study evaluates the effectiveness of Zumba dancing in improving pain, functional capacity, quality of sleep, and quality of life in women with fibromyalgia, finding significant improvements in pain and physical functioning after 12 weeks of intervention.
DOI: 10.1016/j.jbmt.2017.09.022 -
Effects of traditional Chinese exercise therapy on pain scores, sleep quality, and anxiety-depression symptoms in fibromyalgia patients: a systematic review and meta-analysis
Traditional Chinese exercise therapy significantly reduced pain, improved sleep quality, and alleviated anxiety-depression symptoms in fibromyalgia patients, based on a meta-analysis of 15 RCTs with 936 participants.
DOI: 10.1186/s12891-024-07194-7 -
Fibromyalgia: Recent Advances in Diagnosis, Classification, Pharmacotherapy and Alternative Remedies
This narrative review summarizes recent advances in fibromyalgia diagnosis and classification, pharmacotherapy, and alternative therapies, emphasizing the need for positive diagnosis and multidimensional management.
DOI: 10.3390/ijms21217877 -
What Makes Patients with Fibromyalgia Feel Better? Correlations Between Patient Global Impression of Improvement and Changes in Clinical Symptoms and Function: A Pooled Analysis of 4 Randomized Placebo-controlled Trials of Duloxetine
In fibromyalgia, patients’ global impression of improvement after duloxetine treatment aligns strongly with pain reduction and work interference, but is also associated with improvements in fatigue, physical function, mood, and daily living—reflecting the multidimensional nature…
DOI: 10.3899/jrheum.090139 -
Hyperbaric oxygen therapy vs. pharmacological intervention in adults with fibromyalgia related to childhood sexual abuse: prospective, randomized clinical trial
Hyperbaric oxygen therapy yielded greater improvements in fibromyalgia impact, emotional symptoms, daily functioning, and brain perfusion compared with pharmacological treatment for CSA-related fibromyalgia.
DOI: 10.1038/s41598-024-62161-5 -
Pregabalin and Fibromyalgia Syndrome: A Treatment Option
A comprehensive review of pregabalin as a treatment for fibromyalgia, detailing its pharmacology and pharmacokinetics and summarizing four randomized trials (8-, 13-, and 14-week monotherapy plus the FREEDOM trial) that show pregabalin can reduce pain and improve sleep and quali…
DOI: 10.4137/CMT.S1094 -
Pharmacotherapy of Fibromyalgia: Focus on Duloxetine
This narrative review concludes that duloxetine is efficacious and safe for fibromyalgia, supported by placebo-controlled trials and meta-analyses, and recommends starting low and titrating slowly within multimodal therapy.
DOI: 10.4137/cmt.s1162